Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.70
Bid: 23.00
Ask: 24.40
Change: 0.20 (0.85%)
Spread: 1.40 (6.087%)
Open: 23.50
High: 23.70
Low: 23.50
Prev. Close: 23.50
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Contingent Consideration Shares & TVR

18 Apr 2024 10:00

RNS Number : 1721L
Mission Group PLC (The)
18 April 2024
 

18 April 2024

The Mission Group plc

("MISSION" the "Company" or the "Group")

 

Issue of Contingent Consideration Shares, Total Voting Rights

 

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, provides an update on contingent consideration payments in relation to certain of the Group's past acquisitions, Influence Sports & Media ("Influence") and Mezzo Labs Ltd ("Mezzo"), first announced on 8 December 2022 and 14 February 2023 respectively, and more recently referenced in the Group's final results for the year ended 31 December 2023 on 28 March 2024.

 

Under the terms of both acquisitions, deferred consideration contingent on the financial performance of the ongoing businesses is now payable in respect of the first financial year following completion of the acquisitions (the "Contingent Consideration"). The Contingent Consideration is to be satisfied by a combination of cash and Mission shares which has been agreed between the Company and the vendors in accordance with the provisions of the underlying acquisition agreements. As such, the Company will be issuing 2,222,222 ordinary shares in aggregate to the vendors of Influence and Mezzo at the vendors' request, comprising (i) 1,000,000 existing ordinary shares held by the Company's employee benefit trust and (ii) 1,222,222 new ordinary shares in the Company to be issued at a price of 22.5 pence per share based on the Company's average share price over the 10 business days preceding 17 April 2024 (the "New Ordinary Shares").

 

Application has therefore been made for 1,222,222 New Ordinary Shares to be issued to be admitted to trading on AIM with admission expected to take place on 23 April 2024 ("Admission").

 

Following the allotment and issue of the New Ordinary Shares, there will be 92,238,119 ordinary shares in issue. The Company holds no ordinary shares in treasury and therefore this figure may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

ENDS

 

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

Via Houston

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

MISSION is a collective of digital marketing and communications Agencies employing over 1,100 people across 25 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFISAAELSELL
Date   Source Headline
26th Jun 201411:30 amRNSDirector/PDMR Shareholding
16th Jun 201412:24 pmRNSResult of AGM
20th May 20147:00 amRNSThe Mission wins gold at 2014 Roses Creative Award
7th May 20147:00 amRNSBray Leino expands Client offering in Singapore
25th Mar 20147:00 amRNSAudited results for the year ended 31 Dec 2013
21st Jan 20147:00 amRNSTrading Update
3rd Jan 20141:25 pmRNSDirector/PDMR Shareholding
29th Nov 20132:59 pmRNSEBT dealing & Exercise of Options
31st Oct 20137:00 amRNSEBT dealing
30th Oct 20137:00 amRNSEBT dealing
23rd Oct 20137:00 amRNSAcquisition of Solaris Healthcare Network Limited
3rd Oct 20134:44 pmRNSDirector Exercise of Options & EBT dealing
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results
6th Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
28th Jan 20137:00 amRNSTrading Update
25th Jan 20137:00 amRNSNew Client win and further expansion
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 201211:44 amRNSHolding(s) in Company
16th Oct 20122:59 pmRNSHolding(s) in Company
12th Oct 20127:00 amRNSAcquisition, Placing and Board Appointment
24th Sep 20127:00 amRNSAcquisition of Addiction Worldwide
19th Sep 20128:19 amRNSHalf Yearly Report
14th Sep 20123:14 pmRNSNotice of Half Year Results
20th Jul 20127:00 amRNSIssue of LTIP Awards
18th Jul 20127:01 amRNSPre Close Trading Update
18th Jul 20127:00 amRNSChange of Adviser
18th Jun 20121:03 pmRNSResult of AGM
18th Jun 201212:00 pmRNSDirectorate Change
31st May 20121:30 pmRNSContract Award
14th May 20124:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.